Study of elution characteristics of anti-tuberculosis drugs mixed with bone cement
https://doi.org/10.21292/2075-1230-2021-99-4-30-35
Abstract
The objective: to assess the elution characteristics of anti-tuberculosis drugs (isoniazid, cycloserine, rifampicin, amikacin, kanamycin, ethambutol) placed into bone cement samples and put in a liquid medium to determine the possibility of using such systems as a drug reservoir.
Subjects and methods. For in vitro studies, pure substances of the drugs were used. The spectrophotometry was used to study the elution kinetics of the drugs. Absorption spectra of the drugs in the visible and ultraviolet regions were analyzed to reveal the absorption maxima, and the resistance of the chemical structure of the drugs to heating was assessed. Further, the changes of drug release from hardened bone cement samples under static conditions were studied.
Results. It has been found that studied drugs demonstrated satisfactory parameters of thermal stability and elution which makes it possible to use them in a mixture with bone cement.
About the Authors
E. O. PeretsmanasRussian Federation
Evgeniy O. Peretsmanas – Head of Extrapulmonary Tuberculosis Research Department
Build. 2, 4, Dostoevskiy St., Moscow, 127473
A. A. Аrtyukhov
Russian Federation
Aleksandr A. Artyukhov – Professor of Biomaterials Department
9, Miusskaya St., Moscow, 125047
M. I. Shtilman
Russian Federation
Mikhail I. Shtilman – Professor of Biomaterials Department
9, Miusskaya St., Moscow, 125047
I. V. Esin
Russian Federation
Igor V. Esin – Senior Researcher of Extrapulmonary Tuberculosis Research Department
Build. 2, 4, Dostoevskiy St., Moscow, 127473
V. S. Zubikov
Russian Federation
Vladimir S. Zubikov – Leading Researcher of Extrapulmonary Tuberculosis
Research Department
Build. 2, 4, Dostoevskiy St., Moscow, 127473
I. A. Gerasimov
Russian Federation
Ilya A. Gerasimov – Traumatologist and Orthopedist of Extrapulmonary Tuberculosis Unit Department
Build. 2, 4, Dostoevskiy St., Moscow, 127473
References
1. Anagnostakos K., Meyer C. Antibiotic elution from hip and knee acrylic bone cement spacers: a systematic review. BioMed Research International, 2017, vol. 2017.
2. Athans V., Veve M.P., Davis S.L. Trowels and tribulations: review of antimicrobial‐impregnated bone cements in prosthetic joint surgery. Pharmacotherapy, The Journal of Human Pharmacology and Drug Therapy, 2017, vol. 37, no. 12, pp. 1565-1577.
3. Chang C.H., Hu C.C., Chang Y., Hsieh P.H., Shih H.N., Ueng S.W.N.Two-stage revision arthroplasty for Mycobacterium tuberculosis periprosthetic joint infection: An outcome analysis. PloS one, 2018, vol. 13, no. 9, pp. e0203585.
4. Galvez-Lopez R., Pena-Monje A., Antelo-Lorenzo R., Guardia-Olmedo J., Moliz J., Hernandez-Quero J., Parra-Ruiz J. Elution kinetics, antimicrobial activity, and mechanical properties of 11 different antibiotic loaded acrylic bone cement. Diagn. Microbiol. Infect. Dis., 2014, vol. 78, no. 1, pp. 70-74.
5. Han C.D., Oh T., Cho S.N., Yang J.H., Park, K.K. Isoniazid could be used for antibiotic-loaded bone cement for musculoskeletal tuberculosis: an in vitro study. Clinical Orthopedics and Related Research, 2013, vol. 471, no. 7, pp. 2400-2406.
6. Lee J.H., Han C.D., Cho S.N., Yang I.H., Lee W.S., Baek S.H. How long does antimycobacterial antibiotic-loaded bone cement have in vitro activity for musculoskeletal tuberculosis? Clinical Orthopedics and Related Research, 2017, vol. 475, no. 11, pp. 2795-2804.
7. Lee J.H., Shin S.J., Cho S.N., Baek S.H., Park K.K. Does the effectiveness and mechanical strength of kanamycin-loaded bone cement in musculoskeletal tuberculosis compare to vancomycin-loaded bone cement. J. Arthroplasty, 2020, vol. 35, no. 3, pp. 864-869.
8. Masri B.A., Duncan C.P., Jewesson P., Ngui-Yen J., Smith J. Streptomycin-loaded bone cement in the treatm ent of tuberculous osteomyelitis: an adjunct to conventional therapy. Canad. J. Surgery, 1995, vol. 38, no. 1, pp. 64.
Review
For citations:
Peretsmanas E.O., Аrtyukhov A.A., Shtilman M.I., Esin I.V., Zubikov V.S., Gerasimov I.A. Study of elution characteristics of anti-tuberculosis drugs mixed with bone cement. Tuberculosis and Lung Diseases. 2021;99(4):30-35. (In Russ.) https://doi.org/10.21292/2075-1230-2021-99-4-30-35